Filter by: patients

Nupentin Treatment Report

Category: Prescription Drugs

true

Generic Name: Gabapentin

Sort by: Helpfulness | Most Recent

2 patient evaluations for Nupentin

Purposes: Sensory Neuropathy and Diagnostic assessment (Started Jun 28, 2010)
Date Dosage Sensory Neuropathy Perceived effectiveness Diagnostic assessment Perceived effectiveness Side Effects Adherence Burden
Nov 27, 2011 3300 mg Daily Led_efficacy_4Led_efficacy_4Led_efficacy_4Led_efficacy_4Major NoneNoneNoneNoneNone AlwaysAlwaysAlwaysAlwaysAlways Not at allNot at allNot at allNot at allNot at all
May 24, 2011 3300 mg Daily Led_efficacy_3Led_efficacy_3Led_efficacy_3Led_defaultModerate Led_efficacy_3Led_efficacy_3Led_efficacy_3Led_defaultModerate NoneNoneNoneNoneNone AlwaysAlwaysAlwaysAlwaysAlways A littleA littleA littleA littleA little
Feb 17, 2011 900 mg Daily Led_efficacy_4Led_efficacy_4Led_efficacy_4Led_efficacy_4Major NoneNoneNoneNoneNone AlwaysAlwaysAlwaysAlwaysAlways Not at allNot at allNot at allNot at allNot at all
Jun 17, 2010   Led_efficacy_3Led_efficacy_3Led_efficacy_3Led_defaultModerate NoneNoneNoneNoneNone AlwaysAlwaysAlwaysAlwaysAlways Not at allNot at allNot at allNot at allNot at all
Date
May 24, 2011
Advice & Tips
Has reduced the "sunburn like" sympton that I have all over my body.
  • Icon_thumb_off 0 helpful marks
  • jade247
    Sex: F
    Data Quality: 2 stars
    MS: 28 yrs
    Type: Secondary Progressive
    Sensation: Moderate
    Overall: Moderate
    Cognition: moderate
    Vision: moderate
    Speech: mild
    Swallowing: mild
    Upper limb: moderate
    Walking: moderate
  • 768-thumb
  • See jade247's full Nupentin history
Purpose: Stiffness/Spasticity (Started Jun 26, 2009)
Date Dosage Perceived effectiveness Side Effects Adherence Burden
Jul 15, 2009 600 mg Daily Led_efficacy_3Led_efficacy_3Led_efficacy_3Led_defaultModerate MildMildMildMildMild UsuallyUsuallyUsuallyUsuallyUsually Not at allNot at allNot at allNot at allNot at all
Side effects:
Sedation
  • Icon_thumb_off 0 helpful marks

1 additional evaluation for Nupentin is not currently shared publicly.